Maintained robust commercial momentum with over $1 billion in year-to-date automotive awards, reflecting sustained demand for differentiated climate and comfort technologies. Implemented a new operating system focused on labor efficiency and equipment utilization to drive margin expansion and higher cash flow conversion. Advanced medical market strategy through the FDA 510(k) clearance of ThermAffyx, a patient-warming solution derived from core automotive intellectual property. Anticipates closing the Modine Performance Technologies merger in early Q4 2026, transforming the company into a global leader in thermal and precision flow management. Targets over $3.5 billion in revenue by 2030, supported by an estimated $1 billion in cumulative unlevered free cash flow generation through the same period.